PFE Options Are Pricing a $0.75 Move — Our Chart Model Sees $27.55
Pfizer options imply a $27.05–$28.55 range into the October 9 expiration. Put volume tripled and short-dated flow turned defensive, but the stock sits above its key moving averages and below a $28.50 max-pain magnet, so the options read is neutral while the chart model leans lower.
The options market implies a $27.05–$28.55 range for Pfizer into the October 9 expiration. Below: what's driving it, where the levels sit, and three defined-risk ways to trade it.
Published Saturday, October 3, 2026 · Data as of Friday, October 2, 2026 close
Explore the live PFE options data in the Detailed Options Analyzer →
Quick answer
| Item | Answer |
|---|---|
| Market bias | Neutral |
| Options-implied range (into Oct 9) | $27.05 – $28.55 (±2.70%, about ±$0.75) |
| Major support | $27.33 (50-day average). The Oct 9 put wall is $28.50, which sits above spot, so it doesn't act as a floor this week. |
| Major resistance | $28.50 (Oct 9 call wall) |
| Max pain (Oct 9) | $28.50 |
| Dealer gamma regime (estimate) | Positive overall: hedging tends to dampen moves. Flip level ≈ $28, and spot ($27.80) sits just below it. |
| Volatility condition | Rising. IV rank 37/100 · premium rich: options priced ~10 vol pts above delivered movement |
| Technical check | Diverges (bearish; near-term target $27.55, range $27.15–$28.30 by Oct 6; 6-day target $27.55, range $26.85–$28.40) |
| Best-fitting strategy | Iron condor, Oct 9 ($27/$27.50 puts, $28.50/$29 calls) |
| Analysis invalidated if | PFE closes below $27.23 |
1 · What matters today
Pfizer closed Friday at $27.80, and the options market is pricing a move of about 75 cents either way through the October 9 expiration. That is a $27.05–$28.55 range. Our read is neutral.
Friday's flow turned sharply defensive. Traders bought almost two puts for every call. But that hedging is landing on a stock that still trades above its 50-, 100- and 200-day averages. It also sits just under $28.50, the strike where the most option value would expire worthless and where this expiration's heaviest call pile sits.
Options are also priced well above the movement Pfizer has actually delivered, which favors defined-risk premium selling over outright bets. The level that changes the picture is $27.23. A close below it means the hedgers were early, not wrong.
Our chart model leans bearish, toward $27.55, which is a small move inside the options range rather than a break of it.
2 · What the options market is pricing
What changed this week
Pfizer gave back 3.0% over the past five sessions. It slid from $28.72 on September 28–29 to Friday's $27.80, and the options market reacted fast.
Put volume. The put/call volume ratio (how much put activity there is relative to calls; above 1 means puts dominate) ran 0.32 on Wednesday, 0.75 on Thursday and 1.81 on Friday. That is against a 7-day average of 0.61 and a 14-day average of 0.48. Friday's put-buying pace was unusually heavy for this name compared with its own recent history.
Open interest. Contracts held open barely moved. The put/call open-interest ratio sat at 0.70, in line with its 14-day average of 0.71. Traders were renting protection, not rebuilding the book.
Biggest positioning change. The October 9 $28.50 calls added 2,612 contracts to reach 19,579 open. The $28.50 puts in the same expiration added 2,397. That piles even more weight onto a strike that already anchors this expiration.
Implied volatility. IV rose 4.4% over five days.
Settled history. Into Friday's October 2 expiration, the $28.50 puts in that series added 1,835 contracts before settling.
Short vs long trend. The near-term and bigger-picture trends point different ways. Over the past week, price and flow both turned down. Over roughly the past 50 sessions, the stock is still up about 11%, and the flow trend over that stretch reads bullish. A short-term pullback inside a longer uptrend is exactly the setting where heavy put buying tends to be hedging rather than conviction.
Expected move
The expected move is the move the options market is pricing in, derived from what at-the-money straddles cost. For the 6-day window ending October 9 it is ±2.70%, about ±$0.75 around the $27.80 chain price.
| Expiration | Implied move | Range around $27.80 |
|---|---|---|
| Oct 9 (6-day window) | ±2.70% | $27.05 – $28.55 |
| Oct 16 | ±3.97% | $26.70 – $28.90 |
| Oct 30 | ±6.04% | $26.12 – $29.48 |
The ladder widens roughly with the square root of time. There is no unusual step-up between these rungs, so the market isn't pricing a specific event inside the window.
Volatility
Implied volatility (IV) is the market's estimate of how much PFE will move, baked into option prices.
- Level: At-the-money IV is 23.81%. The October 9 contracts carry their own ATM IV near 19.5%, and the ~60-day tenor sits at 25.3%.
- IV rank: 37/100. IV rank shows where today's IV sits versus the past year, so 37/100 means cheaper than 63% of the past year's readings by range. By percentile, today's level beats about 47% of the past year's days, which is middle of the road.
- Direction: IV is climbing. It rose 4.8% on Friday alone, 7.1% over 30 sessions, and now sits above both its 30-day (22.06%) and 90-day (22.33%) averages.
- Term structure: The front-month comparison across expiration dates is unavailable today because Friday was an expiry day.
- Realized movement: Twenty-day realized volatility is only 13.8%, well below this stock's own recent norm. Pfizer has been unusually quiet in actual daily movement even as the options market got nervous.
Premium rich or cheap. The volatility risk premium is the gap between how much movement options are priced for and how much PFE has actually delivered. When it's positive, option sellers have been collecting more than realized movement cost them.
- Size: Right now options are priced about 10 vol points above what PFE has delivered over the past 20 days.
- Versus its own history: The percentile (where today's gap sits versus this stock's own recent readings) is 100/100. The premium is richer than every reading in the recent history, and well above this stock's typical gap.
- Path: The gap widened steadily all week, from about 5 points on September 22 to 10 now. There was no sign flip and no earnings distortion, since the next report is more than a month out and the last one was in early August.
That combination of IV rank 37 and a top-of-range premium over delivered movement favors collecting premium this week, with defined risk.
Skew and sentiment
Skew compares puts and calls the same distance from the stock price. They don't cost the same, and when puts are pricier, traders are paying up for crash protection.
- Headline skew: Pfizer's overall skew is unusual. Calls run about 2.1 vol points richer than equally distant puts, versus a 60-day norm of about 1.9 points. That is basically typical for this name and not a panic signal.
- Recent steepening: Skew has steepened by about 1.8 points toward puts over five sessions.
- 1–4 week options: In this window, puts are priced roughly 7 points richer than their usual relationship to calls. The protection-buying is concentrated in the next few weeks rather than across the whole curve.
Sentiment in short-dated options flipped:
- Options expiring within a week: scored −28, versus a 7-day average of +2.
- The 1–4 week window: scored −25, versus a 7-day average of +21.
- Overall: The curve as a whole reads "mixed." The 60–120 day bucket stayed mildly positive, so longer-dated positioning hasn't joined the defensive turn.
Our leading positioning read also slid to a defensive reading on Friday. Put together, near-term traders bought protection after a two-session drop. The longer-dated book and the price structure still describe an intact uptrend.
The key levels map
| Level | Price | Why it matters |
|---|---|---|
| Call wall (whole chain, all expirations) | $30.00 | Heaviest call open interest across the chain (152,626 contracts); a longer-horizon ceiling |
| 52-week high / swing resistance | $29.21 | Top of the year's range |
| Large gamma strike | $29.00 | Big concentration of option exposure; 6,710 Oct 9 calls open here |
| Top of implied range (Oct 9) | $28.55 | Upper edge of the options-priced move |
| Call wall, put wall and max pain (Oct 9) | $28.50 | The 6-day expiration's heaviest call strike (19,579 open) and heaviest put strike, and the price where the most option value expires worthless. These often act as a magnet into expiration. |
| Swing resistance | $28.40 | Recent pivot high cluster |
| 20-day moving average | $28.01 | Price is 0.8% below it, the first overhead hurdle |
| Gamma flip estimate / large gamma strike | $28.00 | One rough estimate puts the flip here. Above it, market-maker hedging tends to cushion moves; below it, less so. |
| Spot (Oct 2 close) | $27.80 | Where we start |
| Swing support | $27.64 | Nearest pivot support |
| 50-day moving average | $27.33 | Key trend support. Price sits 1.7% above it, and the chart model flags it too. |
| Swing support (invalidation) | $27.23 | A close below breaks the neutral read |
| Bottom of implied range (Oct 9) | $27.05 | Lower edge of the options-priced move |
| Largest gamma strike (whole chain) | $27.00 | Biggest single concentration of option exposure |
| Swing support | $26.49 | Next pivot cluster below |
| 200-day moving average | $26.40 | Long-term trend floor |
| Put wall (whole chain, all expirations) | $25.00 | Heaviest put open interest across all expirations (135,845 contracts) |
| 52-week low | $23.62 | Bottom of the year's range |
Note the disagreement between the two sets of walls. The 6-day expiration's own call wall, put wall and max pain all sit at $28.50. The whole chain's walls sit far wider, at $30 and $25. For the next six days, the $28.50 cluster is the one that matters.
Positioning and unusual flow
Market makers hedge the options they've sold. One rough estimate puts the chain in a positive-gamma regime, where their hedging tends to dampen moves. The October 9 expiration's own estimate reads positive too.
The caveat is location. That same estimate puts the flip level near $28, and spot is sitting just below it, about 0.7% under. Below the flip, market-maker hedging tends to accelerate selling rather than cushion it. That isn't extreme for this name, but it means the dampening effect is thinner at today's price than it would be above $28.
Three non-expired items stand out:
- November 20 $25 puts: 35,213 contracts traded against 24,510 open, roughly $739,000 in premium. This is the single largest piece of Friday's put surge, and it is far out-of-the-money disaster insurance rather than a near-term bet.
- November 6 $32.50–$34 puts: About 4,200 contracts traded across four strikes with no prior open interest, more than $2.4 million in premium. These are deep in the money and behave much like short stock, so read them as a positioning trade rather than a cheap downside lottery ticket.
- October 9 $28.50 calls: The 2,612-contract open-interest build here reinforces the $28.50 cluster for this window.
3 · Technical check
Near-term report (target October 6): bearish.
- Target and range: $27.55, with a projected range of $27.15–$28.30.
- Classification: Diverges. The direction contradicts our neutral options read, even though the target sits comfortably inside the options-implied band.
- Why it leans down: The most decisive reads are a strengthening downtrend reading (ADX near 35, with sellers clearly in control) and money-flow distribution after strongly positive late-September readings.
- Invalidation: Its dominant scenario is invalidated on a push back above about $28.18.
6-day report (target October 9): bearish.
- Target and range: The same $27.55 target, with a wider $26.85–$28.40 range.
- Classification: Diverges on direction.
- Key levels: Support at $27.33 and resistance at $27.93.
- Invalidation: A sustained close above $28.20.
Both models describe a short-term double top whose broken neckline points back toward the 50-day average. They also note that price remains above both the 50-day and 200-day averages.
Model vs. Market: The options market implies $27.05–$28.55 into October 9; the 6-day technical model targets $27.55. That's a 25-cent drift lower inside the priced range, not a break of it. A close below the shared $27.33 support would side with the chart; a return above $28 would side with the $28.50 max-pain magnet.

The TA didn't move the bias, but it shaped the structures. Its $27.55 target sits right on top of the condor's $27.50 short put. That is why the put side gets the tighter management rule below and why the invalidation level sits just under the chart's $27.33 support.
Full technical write-ups: near-term (Oct 6) report → · 6-day (Oct 9) report →
4 · Three ways the next six days can go
If PFE pushes above the call wall ($28.50): Heavy call open interest at $28.50 (19,579 contracts) tends to slow rallies into expiration, especially since max pain sits at the same strike. A clean break would leave thinner positioning overhead until the $29 strike and the $29.21 52-week high. That is also the top edge of what the options are pricing.
If PFE drifts between $27.33 and $28.50: This is the pin case. Max pain at $28.50 sits 70 cents above spot. Positive dealer gamma, as estimated, tends to dampen swings. Together they describe a market where expiring open interest and hedging flows lean toward pulling price up and in rather than pushing it out. This is the branch the iron condor is built for.
If PFE breaks below the 50-day average ($27.33): This is the acceleration case. Spot is already slightly below the ~$28 gamma flip estimate, where one rough estimate suggests market-maker hedging amplifies selling rather than cushioning it. A break of the 50-day average would put the stock through the chart model's key support and on toward the $27.05 lower rail. There, Friday's put buyers would start getting paid.
5 · Three defined-risk structures
Prices are end-of-day midpoints as of October 2, 2026. All structures are hypothetical unless flagged as an entered position. Verify live prices before trading; these will be stale by the open.
With the premium over delivered movement at the top of its recent range, the credit structure leads. A reminder on mechanics: a credit spread collects cash up front and profits if the stock stays away from the short strike. A debit spread pays up front and profits if the stock moves toward the short strike.
If you expect the range to hold: Iron condor
- Trade: Sell Oct 9 $27.50 put / buy $27 put; sell Oct 9 $28.50 call / buy $29 call
- Credit: $0.145 ($14.50 per condor) · Max profit: $14.50 · Max loss: $35.50 · Break-evens: $27.355 and $28.645
- Why it fits: Options are priced about 10 vol points above delivered movement, and that premium is the richest in this stock's recent history. The short call sits at the $28.50 call wall and max pain, the strike positioning most often defends into expiration.
- Makes sense only if: You accept that the short put sits just 30 cents below spot and right at the chart model's $27.55 target. This is a bet on the pin, not on comfortable distance.
- Invalidated if: PFE closes below $27.23
- Managing it: Close at about 50% of the credit. Close the put side immediately on a close below $27.50 rather than waiting for the invalidation level. Exit everything by the October 8 close to avoid expiration-day pin risk at $28.50.
- Liquidity note: The $27.50 puts are quoted 4¢ wide ($0.15/$0.19), the $27 puts 1¢, the $28.50 calls 2¢ and the $29 calls 2¢. Those are tight in cents but large relative to a 14.5-cent total credit. Work a limit order at mid; giving up even a few cents changes the risk/reward materially.
- Analyze this position →
If you lean bullish: Put credit spread
- Trade: Sell Oct 9 $27.50 / $27 put credit spread
- Credit: $0.105 ($10.50) · Max profit: $10.50 · Max loss: $39.50 · Break-even: $27.395
- Why it fits: The stock sits above its 50-, 100- and 200-day averages, and max pain at $28.50 is overhead. If Friday's put surge was hedging into an intact uptrend, that hedging premium is what you're collecting.
- Makes sense only if: The $27.33 50-day average holds on any test early in the window.
- Invalidated if: PFE closes below $27.23
- Managing it: Take 50% of the credit if offered. With the past week's pullback fighting the longer uptrend, don't hold through a second down day; exit by the October 8 close regardless.
- Liquidity note: The $27.50 puts trade 4¢ wide and the $27 puts 1¢ wide. Fill at or near mid or skip it.
- Analyze this position →
If you lean bearish: Put debit spread
- Trade: Buy Oct 9 $28 put / sell $27.50 put
- Debit: $0.225 ($22.50) · Max profit: $27.50 · Max loss: $22.50 · Break-even: $27.775
- Why it fits: In this expiration, at-the-money puts are priced at lower IV than calls (about 17.7% vs 21.3% at the $28 strike), so buying downside is the cheaper side of the chain. The spread targets the chart model's $27.55 projection.
- Makes sense only if: Short-dated flow stays defensive and the stock fails to reclaim $28, where the gamma flip estimate sits.
- Invalidated if: PFE closes above $28.40
- Managing it: Take profits near $27.50. Close if the stock reclaims $28 on a closing basis, since that puts it back on the cushioned side of the flip estimate and closer to the $28.50 magnet.
- Liquidity note: The $28 puts trade 5¢ wide ($0.37/$0.42) and the $27.50 puts 4¢ wide. Price the spread as a single order at mid.
- Analyze this position →
If none of these: no trade
The premium is genuinely rich and not earnings-inflated, so standing aside needs a reason. Here are four:
- The cents are tiny. On a $28 stock with a 75-cent expected move, every structure above collects or risks only cents. A couple of pennies of slippage per leg can erase much of the edge that rich premium offers.
- The short strikes are close. They sit inside the expected move, in the final week, when small moves swing option values fastest.
- Spot is on the fragile side. It sits just below the gamma flip estimate, with put volume running at nearly four times its two-week average.
- The rich premium is still available later. If you can't watch the position daily, the same richness shows up in later expirations, such as October 16, with more room around the strikes.
6 · Quick FAQ
What is PFE's expected move this week? About ±$0.75 (±2.70%) into the October 9 expiration, a $27.05–$28.55 range, per the options market's straddle pricing as of October 2, 2026.
Is PFE expected to go up or down over the next week? Options positioning as of October 2 reads neutral. Short-dated flow turned defensive, but the stock sits above its key averages and below a $28.50 max-pain magnet. That's a read of what traders have done, not a forecast. The actionable map is the $27.05–$28.55 range, $27.33 support and $28.50 resistance.
Are PFE options expensive right now? IV rank of 37/100 says option prices are higher than about 37% of the past year's range, which is middling. On top of that, they're running about 10 vol points above the movement PFE has actually delivered, richer than every reading in this stock's recent history. That favors defined-risk premium selling, provided you can get fills near mid.
Where is PFE's biggest options support and resistance? For the October 9 expiration, the call wall, put wall and max pain all sit at $28.50, making it the week's magnet and ceiling. Practical support is the $27.33 50-day average. Across all expirations, the walls sit at $30 (calls) and $25 (puts).
What invalidates this week's read? A close below $27.23.
Methodology & disclosures. Data: end-of-day options-chain snapshot for PFE, 2026-10-02, generated 2026-10-03T21:27:34.645Z. Prices shown are midpoints and will differ from live markets. Momentum/positioning scores and volatility-premium comparisons are descriptive measurements of past option flow and past price movement — not investment advice, signals, forecasts, or guarantees. All trade structures are hypothetical. Every structure shown has a defined maximum loss; you can lose the entire max-loss amount. Options involve substantial risk and are not suitable for all investors.